Global Drug Screening Market Size, Trends, & Growth, Opportunity, By Product and service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), By Sample Type, By End User,

Global Drug Screening Market Size, Trends, & Growth, Opportunity, By Product and service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), By Sample Type, By End User, By Region, and Forecast till 2027.

Global Drug Screening Market

Global Drug Screening Market was valued at US$ 6.9 Billion in 2021 and is estimated to reach US$16.54 Billion in 2027, exhibiting a CARG of 15.97% during the forecast period 2022 to 2027.

Global Drug Screening Market defined as” the technical procedure that involves evaluating samples such as hair, urine, oral secretions, breath, and other substances. Drug screening is a technique for detecting drugs or chemical compounds in the human body. Hospitals, drug testing centres, pain management centres, and law enforcement organisations all use this method. Drug testing is also done on employees and athletes by firms and organisations to check for drug usage.

Market Drivers

Increased drug and alcohol consumption, as well as the application of strict legislation requiring drug and alcohol testing, will all denote to the global drug screening market's rise in the near future. In addition, regulatory approvals and government backing in key markets are expected to fuel market growth in the coming years. On the contrary, restrictions on alcohol consumption in many Islamic countries and the prohibition of drug testing at workplaces in other locations are two major worries that could hinder the worldwide drug screening market's growth in the near future.

In emerging countries like China, rising rates of drug use among adults and teenagers have hampered employment and hampered the country's economic situation, which is anticipated to become a major factor contributing to market expansion. In addition, non-profit organization.

ns and the government focus their efforts on funding drug screening programs, thereby improving drug screening technologies. Despite the industry's rapid growth, certain governmental and social decisions may constrain its expansion. Political policies, such as the restriction of alcohol consumption in some countries, could have a negative impact in the near future. COVID-19 has caused substantial disruptions in global economic and corporate activities, and it is expected to have a temporary negative impact on the global drug screening market.

Market Restraints

Major factors such as workplace prohibitions against drug and alcohol testing in some locations, employee privacy violations, and the need for physician approval for drug testing may limit market growth to some extent. Increased alcohol prohibition in some countries, as well as specificity difficulties with breathalyzers, will pose additional.

Prohibitions in various countries may hinder the adoption of drug & alcohol testing in these markets, thus restraining overall market growth to a certain extent.

Market Segmentation

Global Drug Screening market is segmented into By Product & Service, By sample, By end user, By Country. By Product & Service the market is segmented into (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service). By Sample market is segmented into (Urine Samples, Breath Samples, Fluid Samples, Hair Samples, Other Samples). By End User market is segmented into (Drug Testing Laboratories Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers Individual Users, Pain Management Centers, Schools and Colleges).

Regional Analysis

Global Drug Screening Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. North America was the largest regional segment of the overall market with a share of 48.2%, followed by Europe.

Key Players

Key companies across the Drug Screening Market include Biotech (US), Omega Laboratories (US), Drägerwerk (Germany), Thermo Fisher Scientific (US), Alfa Scientific Designs (US), OraSure Technologies (US), Abbott Laboratories (US), Quest Diagnostics (US), LabCorp (US).

Market Taxonomy

By Product & Service

• Drug Screening Product
• Analytical Instruments
• Breathalyzers
• Fuel Cell Breathalyzer
• Semiconductor Breathalyzer
• Other Breathalyzers
• Immunoassay Analyzer
• Chromatography Instruments
• Rapid Testing Devices
• Urine Testing Devices
• Drug Testing Cups
• Dip Cards
• Drug Testing Cassetts
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Devices
• Calibrators & Controls
• Other Consumables
• Drug Screening Service

• Urine Samples
• Breath Samples
• Fluid Samples
• Hair Samples
• Other Samples

• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa